Device suppliers to UK must heed new tissue rules
This article was originally published in Clinica
The UK's Medical Devices Agency has become the first regulatory authority in the EU to issue guidelines on standards for organisations supplying the health service with medical devices using material of human origin. The UK is reacting to an urgent need for some sort of regulation in this area while awaiting official regulatory developments at the European Commission (see above), which have been slow.
You may also be interested in...
The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.